Chitosan oligosaccharides promote reverse cholesterol transport and expression of scavenger receptor BI and CYP7A1 in mice

Experimental Biology and Medicine

Volumn 237, Issue 2, 2012, Pages 194-200

  Zong, Chuanlong ^a   Yu, Yang ^a   Song, Guohua ^a   Luo, Tian ^a   Li, Luqin ^a   Wang, Xinnong ^a   Qin, Shucun ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

Author keywords

Chitosan oligosaccharides; Cholesterol 7 alpha hydroxylase; Reverse cholesterol transport; Scavenger receptor BI

Indexed keywords

CHITOSAN DERIVATIVE; CHITOSAN OLIGOSACCHARIDE; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; LIVER PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; OLIGOSACCHARIDE; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; BETA ACTIN; COMPLEMENTARY DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BILE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FECES; FEMALE; GENE EXPRESSION; IN VIVO STUDY; LIPID BLOOD LEVEL; LIVER; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; CHOLESTEROL METABOLISM; DENSITOMETRY; DRUG EFFECT; LIQUID SCINTILLATION COUNTING; MRNA EXPRESSION ASSAY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD36; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CELL LINE; CHITOSAN; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; FEMALE; HUMANS; LIVER; MACROPHAGES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; OLIGOSACCHARIDES;

EID: 84863148724     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011275     Document Type: Article

References (26)

1. Assmann G, Cullen P, Jossa F, Lewis B, Mancini M. Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart Disease. Arterioscler Thromb Vasc Biol 1999;19:1819-24
2. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005;96:1221-32
3. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996;271:518-20
4. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, Rader DJ. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 2005;115:2870-4
5. Kozarsky KF, Donahee MH, Glick JM, Krieger M, Rader DJ. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000;20:721-7
6. Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res 2009;50 (Suppl):S189-194
7. Naik SU, Wang X, Da Silva JS, Jaye M, Macphee CH, Reilly MP, Billheimer JT, Rothblat GH, Rader DJ. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 2006;113:90-7
8. Moon MS, Lee MS, Kim CT, Kim Y. Dietary chitosan enhances hepatic CYP7A1 activity and reduces plasma and liver cholesterol concentrations in diet-induced hypercholesterolemia in rats. Nutr Res Pract 2007;1:175-9
9. Aam BB, Heggset EB, Norberg AL, Sorlie M, Varum KM, Eijsink VG. Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs 2010;8:1482-1517
10. Xu G, Huang X, Qiu L, Wu J, Hu Y. Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats. Asia Pac J Clin Nutr 2007;16(Suppl 1):313-7
11. Ormrod DJ, Holmes CC, Miller TE. Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 1998;138:329-34
12. Wang DX, Han JJ, Yu Y, Li X, Wang Y, Tian H, Guo SD, Jin S, Luo T, Qin SC. Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed rats. Exp Biol Med 2011;236:1064-9
13. Miyazaki A, Sakai M, Suginohara Y, Hakamata H, Sakamoto Y, Morikawa W, Horiuchi S. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein. J Biol Chem 1994;269:5264-9
14. Yu Y, Si YH, Song GH, Luo T, Wang JF, Qin SC. Ethanolic extract of propolis promotes reverse cholesterol transport and the expression of ATP-binding cassette transporter A1 and G1 in mice. Lipids 2011;46:805-11
15. Song GH, Liu J, Zhao ZM, Yu Y, Tian H, Yao ST, Li G, Qin SC. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet. Lipids Health Dis 2011;10: 8-14
16. Van Eck M, Pennings M, Hoekstra M, Out R, Van Berkel TJ. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 2005;16:307-15
17. Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol 2010;30:139-43
18. Trigatti BL, Krieger M, Rigotti A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:1732-8
19. Malerod L, Juvet LK, Hanssen-Bauer A, Eskild W, Berg T. Oxysterol-activated LXRalpha/ RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem Biophys Res Commun 2002;299:916-23
20. Chiang JY. Bile acids: regulation of synthesis. J Lipid Res 2009;50:1955-66
21. Schmitz G, Langmann T, Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism. J Lipid Res 2001;42:1513-20
22. Shen J, Ye XY, Shen J, Jin BS, Wang YF. Studies on the effect of chito oligosaccharide on reducing lipid and protecting liver of chito oligosaccharide in hyperlipidemia mice. J Northwest A & F Univ (Nat Sci Ed) 2007;35:35-8
23. Zhou TX, Chen YJ, Yoo JS, Huang Y, Lee JH, Jang HD, Shin SO, Kim HJ, Cho JH, Kim IH. Effects of chitooligosaccharide supplementation on performance, blood characteristics, relative organ weight, and meat quality in broiler chickens. Poult Sci 2009;88:593-600
24. Wagner M, Zollner G, Trauner M. Nuclear receptors in liver disease. Hepatology 2011;53:1023-34
25. Kostapanos MS, Milionis HJ, Elisaf MS. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Am J Cardiovasc Drugs 2010;10:11-28
26. Negishi K, Noiri E, Maeda R, Portilla D, Sugaya T, Fujita T. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int 2008;73:1374-84